PharmaDepth
beta
Catalyst
Company
Drug
Company Information
Viatris Inc. (VTRS)
Overview
Products
Trials
Market Cap
$14.93B
Revenue TTM
Earnings Date
2025-02-26
Website
https://www.viatris.com
Upcoming PDUFA Dates
No upcoming PDUFAs found
Upcoming Trial Readouts
Feature coming soon
Upcoming Patent Expirations
Brand Name
Patent Number
Expire Date
TOBI PODHALER
8664187
6/20/2025
EPI E Z PEN JR
7449012
9/11/2025
EPI E Z PEN JR
7794432
9/11/2025
EPI E Z PEN JR
8048035
9/11/2025
EPI E Z PEN JR
8870827
9/11/2025
EPI E Z PEN JR
9586010
9/11/2025
EPIPEN
7449012
9/11/2025
EPIPEN
7794432
9/11/2025
EPIPEN
8048035
9/11/2025
EPIPEN
8870827
9/11/2025
EPIPEN
9586010
9/11/2025
EPIPEN E Z PEN
7449012
9/11/2025
EPIPEN E Z PEN
7794432
9/11/2025
EPIPEN E Z PEN
8048035
9/11/2025
EPIPEN E Z PEN
8870827
9/11/2025
EPIPEN E Z PEN
9586010
9/11/2025
EPIPEN JR.
7449012
9/11/2025
EPIPEN JR.
7794432
9/11/2025
EPIPEN JR.
8048035
9/11/2025
EPIPEN JR.
8870827
9/11/2025
EPIPEN JR.
9586010
9/11/2025
TOBI PODHALER
7559325
10/27/2025
ASTEPRO
8518919
11/22/2025
ASTEPRO
9919050
11/22/2025
DYMISTA
8168620
2/24/2026
DYMISTA
8168620*PED
8/24/2026
LYRICA CR
10022447
11/2/2026
LYRICA CR
8945620
11/2/2026
LYRICA CR
9144559
11/2/2026
EDLUAR
9597281
4/6/2027
LYRICA CR
10022447*PED
5/2/2027
LYRICA CR
8945620*PED
5/2/2027
LYRICA CR
9144559*PED
5/2/2027
ROWASA
7645801
7/24/2027
SFROWASA
7645801
7/24/2027
VUSION
8147852
3/30/2028
ASTEPRO
8071073
6/4/2028
TOBI PODHALER
8869794
9/12/2028
YUPELRI
7288657
10/31/2028
YUPELRI
10550081
7/14/2030
YUPELRI
11008289
7/14/2030
YUPELRI
11691948
7/14/2030
YUPELRI
11858898
7/14/2030
YUPELRI
9765028
7/14/2030
TOBI PODHALER
10207066
11/4/2030
EDLUAR
9265720
2/25/2031
YUPELRI
8541451
8/25/2031
ERMEZA
9345772
2/27/2035
YUPELRI
12048692
8/29/2039
YUPELRI
11484531
10/23/2039